Research ArticleResearchPatient Education

Decision coaching helped more undecided BRCA carriers reach a preventive decision

PloS one (PubMed)Aug 17, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

An exploratory randomized-trial subgroup analysis found that structured decision coaching helped more initially undecided BRCA1/2 carriers with open family planning reach a preventive-care decision than usual care.

What NurseJet pulled from the source

Participants without a personal cancer history received usual care or in-person coaching plus an evidence-based decision aid covering intensified breast surveillance, risk-reducing mastectomy, and risk-reducing salpingo-oophorectomy. Among initially undecided participants with open family planning, 61.8% in the intervention group versus 23.3% with usual care had reached a decision at 12 weeks.

Why this matters for nurses

Oncology nurses often help patients navigate hereditary-cancer information, competing reproductive priorities, and emotionally difficult preventive choices. The study supports structured decision support while preserving the patient's values and avoiding pressure toward a particular operation or surveillance plan.

Bedside takeaway

Structured coaching can reduce BRCA-related decision conflict while keeping surveillance, surgery, and reproductive timing centered on informed patient preferences.

How This Applies in Practice

Use this when: Supporting a BRCA1/2 carrier without cancer who is weighing preventive options while family planning remains open.

On your shift

Assess the patient's current understanding, preferred role in decisions, unanswered questions, and how reproductive goals affect timing.
Offer the organization's approved decision aid and connect the patient with genetics, oncology, gynecology, or fertility counseling as appropriate.
Document preferences and decisional uncertainty separately from consent, and arrange follow-up when the patient is not ready to decide.

Keep in mind: The study evaluated decision support, not which preventive choice is best. Follow the multidisciplinary plan, facility policy, and provider orders.

Key takeaways

BRCA1/2 carriers with open family planning began with greater decisional conflict than those who had completed family planning.
Decision coaching combined an in-person session with a structured, evidence-based aid describing preventive options.
Among initially undecided participants with open family planning, more reached a preventive decision by 12 weeks with coaching than with usual care.
The analysis was exploratory and assessed decision process outcomes, not cancer incidence, survival, or the clinical superiority of any option.

Practice implications

Clarify what the patient understands about each option, ask how family-planning goals affect timing, and connect unresolved questions to genetics, oncology, gynecology, or fertility specialists through the established pathway. Document preferences and uncertainty without presenting decision completion as consent for a specific intervention.

Limitations & cautions

This was an exploratory subgroup analysis of a randomized trial, and the abstract does not report subgroup size or long-term clinical outcomes. Reaching a decision does not establish that the decision was durable, preferred later, or medically superior.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

PloS one (PubMed)

PloS one (PubMed). Decision coaching for healthy women with BRCA1/2 pathogenic variants and open family planning: Impact on decisional conflict and decision status: Subgroup analyses from a randomized controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42607047/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Journal of midwifery & women's health (PubMed)Sep 7, 2026Research Article

A retrospective analysis of US natality data found no statistically significant yearly difference in neonatal mortality between freestanding birth centers and hospitals among term, singleton, vertex births without major medical risk factors from 2015 through 2024.

L&D / OB PedsAI summaryReview source

Research ArticleResearchPatient EducationAI summary · original source linked below

Adjusted neonatal-mortality odds for freestanding birth centers fluctuated around 1.0 across the 10-year study period. No individual year showed a statistically significant difference from hospital births, including 2020 and 2021 when birth-center volume increased.

Key takeaways

The analysis was restricted to births meeting selected low-risk criteria.
The study found no evidence that higher birth-center use during the pandemic years increased neonatal mortality.
The observational design cannot establish that birth setting itself caused the mortality pattern.

Why this matters on shift

The findings add national outcome data for counseling and systems planning around freestanding birth-center care for appropriately selected low-risk pregnancies.

Bedside takeaway

Apply local eligibility, surveillance, escalation, and transfer protocols when caring for planned low-risk birth-center patients.

Nursing implications

Keep eligibility, surveillance, escalation, and transfer decisions anchored to local birth-center criteria and maternal-newborn protocols.

Limitations & cautions

Abstract-only summary. The study used retrospective vital-record data, was limited to selected low-risk births, and cannot exclude residual differences between people who delivered in birth centers and hospitals.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of midwifery & women's health (PubMed). Neonatal Mortality Risk Among Births in Freestanding Birth Centers, 2015 to 2024.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Supportive care in cancer (PubMed)Sep 5, 2026Research Article

A small randomized trial found larger one-month reductions in reported supportive-care needs among colorectal cancer caregivers who received smartphone-based education than with routine care.

OncologyAI summaryReview source

Research ArticleResearchPatient EducationAI summary · original source linked below

Eighty family caregivers at two teaching hospitals in Tehran were randomized. Compared with routine care, the intervention group reported larger reductions in total needs and in health-service, psychological-emotional, work-social, and information domains after four weeks.

Key takeaways

The intervention was designed around family caregivers' supportive-care needs.
All four measured need domains favored the smartphone-education group at four weeks.
The abstract reports statistical significance but does not provide effect sizes or describe the educational content in detail.

Why this matters on shift

Caregiver education is part of oncology care, and mobile delivery may extend structured support beyond brief in-person teaching encounters.

Bedside takeaway

Ask caregivers about unmet information and support needs, then reinforce teaching with approved digital resources.

Nursing implications

Assess what caregivers still need to know and use approved digital education as a supplement to individualized teaching and follow-up.

Limitations & cautions

Abstract-only summary. The trial included 80 caregivers at two hospitals, assessed self-reported needs after only four weeks, and did not report patient outcomes or effect sizes in the abstract.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Supportive care in cancer (PubMed). The effect of a smartphone-based educational intervention on the supportive care needs of family caregivers of patients with colorectal cancer: a randomized controlled trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

The Cochrane database of systematic reviews (PubMed)Sep 4, 2026Systematic Review

An updated Cochrane review found that long-term hormone-therapy risk profiles differed between combined therapy and estrogen-only therapy.

Med-Surg L&D / OBAI summaryReview source

Systematic ReviewResearchMedication SafetyPatient EducationAI summary · original source linked below

The review included 24 randomized, double-blind trials with 45,660 participants. Most participants were postmenopausal, the mean age in most studies exceeded 60 years, and nearly 70% of the data came from HERS and the Women's Health Initiative.

Key takeaways

Combined therapy probably increased breast-cancer risk and may have increased stroke and venous-thromboembolism risk.
Estrogen-only therapy probably increased stroke and gallbladder-surgery risk while reducing clinical fractures.
Findings were driven largely by older oral regimens and may not represent hormone therapy used today.

Why this matters on shift

Medication reconciliation and patient teaching should account for the specific hormone regimen rather than treating all hormone therapy as one exposure.

Bedside takeaway

Confirm the prescribed formulation and promptly communicate new thromboembolic, neurologic, or gallbladder symptoms through the care team.

Nursing implications

Confirm the prescribed formulation and promptly communicate new thromboembolic, neurologic, or gallbladder symptoms through the care team.

Limitations & cautions

Abstract-only summary. The review addressed therapy lasting at least one year, not short-term symptom relief. Most participants were older than the group most likely to seek treatment for vasomotor symptoms.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

The Cochrane database of systematic reviews (PubMed). Long-term hormone therapy for perimenopausal and postmenopausal women.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Low-risk birth-center births showed no higher neonatal mortality in a 10-year analysis

Smartphone education reduced reported support needs among colorectal cancer caregivers

Long-term menopausal hormone therapy has formulation-specific benefits and harms